Efemoral Medical develops a minimally invasive intravascular scaffold system for treating femoropopliteal lesions in peripheral arterial disease. The patented scaffold, delivered via a low‑profile catheter, offers high radial strength and fatigue resistance while remaining flexible to reduce fracture, migration, and restenosis, aiming to improve long‑term vessel patency. The solution targets vascular surgeons, interventional cardiologists, and interventional radiology departments seeking durable, less traumatic peripheral interventions.
Funding
$4.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Peripheral arterial disease (PAD) affects hundreds of millions worldwide, causing reduced blood flow, pain, and risk of limb loss. Current endovascular treatments often rely on conventional stents that can fracture, migrate, or provoke restenosis, leading to repeat procedures and higher healthcare costs.
Solution
Efemoral Medical is developing a durable, minimally invasive intravascular scaffold system designed specifically for femoropopliteal lesions in PAD patients. The scaffold is delivered via a low-profile catheter, allowing treatment in peripheral vessels with reduced procedural trauma. Its proprietary alloy and geometry provide enhanced radial strength while maintaining flexibility to accommodate vessel movement, aiming to lower fracture rates and improve long‑term patency. Early clinical data (EFEMORAL I) demonstrate sustained vessel support and differentiated performance over multiple years. The company has secured multiple patents and received Breakthrough Device Designation, underscoring the novelty and regulatory promise of the technology.
Target Audience
Primary customers are vascular surgeons, interventional cardiologists, and hospital interventional radiology departments that treat peripheral arterial disease.
Features
- Minimally invasive catheter delivery system optimized for femoropopliteal anatomy
- Patented intravascular scaffold with high radial strength and fatigue resistance
- Flexible design that conforms to vessel motion, reducing fracture and migration risk
- Long‑term durability demonstrated in first‑in‑human and extended follow‑up studies
- Compatibility with standard imaging and guidewire techniques used in peripheral interventions